vs

Side-by-side financial comparison of Cambium Networks Corp (CMBM) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $21.8M, roughly 1.8× NEKTAR THERAPEUTICS). Cambium Networks Corp runs the higher net margin — -17.9% vs -165.4%, a 147.5% gap on every dollar of revenue. On growth, Cambium Networks Corp posted the faster year-over-year revenue change (-23.2% vs -25.3%). Cambium Networks Corp produced more free cash flow last quarter ($-10.8M vs $-65.0M). Over the past eight quarters, NEKTAR THERAPEUTICS's revenue compounded faster (0.4% CAGR vs -27.2%).

Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

CMBM vs NKTR — Head-to-Head

Bigger by revenue
CMBM
CMBM
1.8× larger
CMBM
$40.3M
$21.8M
NKTR
Growing faster (revenue YoY)
CMBM
CMBM
+2.1% gap
CMBM
-23.2%
-25.3%
NKTR
Higher net margin
CMBM
CMBM
147.5% more per $
CMBM
-17.9%
-165.4%
NKTR
More free cash flow
CMBM
CMBM
$54.2M more FCF
CMBM
$-10.8M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
NKTR
NKTR
Annualised
NKTR
0.4%
-27.2%
CMBM

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CMBM
CMBM
NKTR
NKTR
Revenue
$40.3M
$21.8M
Net Profit
$-7.2M
$-36.1M
Gross Margin
36.6%
Operating Margin
-28.4%
-126.9%
Net Margin
-17.9%
-165.4%
Revenue YoY
-23.2%
-25.3%
Net Profit YoY
71.0%
-596.9%
EPS (diluted)
$-0.26
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBM
CMBM
NKTR
NKTR
Q4 25
$21.8M
Q3 25
$11.8M
Q2 25
$11.2M
Q1 25
$10.5M
Q4 24
$40.3M
$29.2M
Q3 24
$44.7M
$24.1M
Q2 24
$45.2M
$23.5M
Q1 24
$47.1M
$21.6M
Net Profit
CMBM
CMBM
NKTR
NKTR
Q4 25
$-36.1M
Q3 25
$-35.5M
Q2 25
$-41.6M
Q1 25
$-50.9M
Q4 24
$-7.2M
$7.3M
Q3 24
$-34.5M
$-37.1M
Q2 24
$-14.2M
$-52.4M
Q1 24
$-18.4M
$-36.8M
Gross Margin
CMBM
CMBM
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
36.6%
72.7%
Q3 24
43.6%
81.6%
Q2 24
32.5%
58.5%
Q1 24
29.8%
60.6%
Operating Margin
CMBM
CMBM
NKTR
NKTR
Q4 25
-126.9%
Q3 25
-268.6%
Q2 25
-324.2%
Q1 25
-425.8%
Q4 24
-28.4%
49.2%
Q3 24
-69.6%
-142.4%
Q2 24
-27.2%
-211.9%
Q1 24
-33.1%
-163.7%
Net Margin
CMBM
CMBM
NKTR
NKTR
Q4 25
-165.4%
Q3 25
-301.3%
Q2 25
-372.2%
Q1 25
-486.4%
Q4 24
-17.9%
24.9%
Q3 24
-77.3%
-153.6%
Q2 24
-31.5%
-222.9%
Q1 24
-39.2%
-170.1%
EPS (diluted)
CMBM
CMBM
NKTR
NKTR
Q4 25
$-4.67
Q3 25
$-1.87
Q2 25
$-2.95
Q1 25
$-0.24
Q4 24
$-0.26
$-2.07
Q3 24
$-1.22
$-2.66
Q2 24
$-0.51
$-3.76
Q1 24
$-0.66
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBM
CMBM
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$15.1M
Total DebtLower is stronger
$67.6M
Stockholders' EquityBook value
$-3.2M
$89.8M
Total Assets
$173.7M
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBM
CMBM
NKTR
NKTR
Q4 25
$15.1M
Q3 25
$41.0M
Q2 25
$43.0M
Q1 25
$38.9M
Q4 24
$44.3M
Q3 24
$30.1M
Q2 24
$27.9M
Q1 24
$48.6M
Total Debt
CMBM
CMBM
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$67.6M
Q3 24
$67.6M
Q2 24
$68.9M
Q1 24
$63.8M
Stockholders' Equity
CMBM
CMBM
NKTR
NKTR
Q4 25
$89.8M
Q3 25
$85.1M
Q2 25
$-24.2M
Q1 25
$13.7M
Q4 24
$-3.2M
$60.7M
Q3 24
$1.9M
$48.9M
Q2 24
$34.1M
$79.7M
Q1 24
$45.0M
$126.7M
Total Assets
CMBM
CMBM
NKTR
NKTR
Q4 25
$280.4M
Q3 25
$301.3M
Q2 25
$207.5M
Q1 25
$256.2M
Q4 24
$173.7M
$303.9M
Q3 24
$194.3M
$308.0M
Q2 24
$221.1M
$343.3M
Q1 24
$219.8M
$396.0M
Debt / Equity
CMBM
CMBM
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
36.12×
Q2 24
2.02×
Q1 24
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBM
CMBM
NKTR
NKTR
Operating Cash FlowLast quarter
$-10.4M
$-65.0M
Free Cash FlowOCF − Capex
$-10.8M
$-65.0M
FCF MarginFCF / Revenue
-26.8%
-298.0%
Capex IntensityCapex / Revenue
1.1%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.4M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBM
CMBM
NKTR
NKTR
Q4 25
$-65.0M
Q3 25
$-48.8M
Q2 25
$-45.7M
Q1 25
$-49.1M
Q4 24
$-10.4M
$-46.2M
Q3 24
$8.9M
$-43.9M
Q2 24
$2.4M
$-37.7M
Q1 24
$-15.9M
$-47.9M
Free Cash Flow
CMBM
CMBM
NKTR
NKTR
Q4 25
$-65.0M
Q3 25
$-48.9M
Q2 25
$-45.8M
Q1 25
$-49.1M
Q4 24
$-10.8M
$-46.6M
Q3 24
$6.8M
$-44.6M
Q2 24
$87.0K
$-37.9M
Q1 24
$-17.4M
$-48.0M
FCF Margin
CMBM
CMBM
NKTR
NKTR
Q4 25
-298.0%
Q3 25
-414.5%
Q2 25
-409.6%
Q1 25
-469.0%
Q4 24
-26.8%
-159.9%
Q3 24
15.2%
-184.9%
Q2 24
0.2%
-161.3%
Q1 24
-37.0%
-222.0%
Capex Intensity
CMBM
CMBM
NKTR
NKTR
Q4 25
0.1%
Q3 25
1.0%
Q2 25
0.3%
Q1 25
0.0%
Q4 24
1.1%
1.6%
Q3 24
4.8%
2.8%
Q2 24
5.1%
0.8%
Q1 24
3.3%
0.7%
Cash Conversion
CMBM
CMBM
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-6.36×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMBM
CMBM

Enterprise$16.6M41%
Point To Multi Point$16.4M41%
Other$5.8M14%

NKTR
NKTR

Segment breakdown not available.

Related Comparisons